New Trojan Horse Cancer Treatment Shows Early Promise in Multiple Tumour Types

New ‘Trojan Horse’ Cancer Treatment Shows Early Promise in Multiple Tumour Types

A brand new type of cancer drug that acts as a ‘Trojan horse’ to get inside tumour cells has shown promise in patients with six different cancer types. In patients with advanced, drug-resistant cancers, over a quarter with cervical and bladder tumours, and nearly 15 per cent with ovarian and lung tumours, responded to the new treatment. The innovative new drug, called tisotumab vedotin (or TV for short)...

More From BioPortfolio on "New ‘Trojan Horse’ Cancer Treatment Shows Early Promise in Multiple Tumour Types"